George, D. J., Howard, L. E., Halabi, S., Hyslop, T., LaCroix, B., Hurrelbrink, J., … Freedman, J. A. (2025). Abstract C117: Serum dehydroepiandrosterone sulfate (DHEAS) and race associated with longer survival in patients (pts) treated with apalutamide (Apa) and abiraterone acetate (AA) plus prednisone (P) in the PANTHER study. In Cancer Epidemiology, Biomarkers & Prevention (Vol. 34, pp. C117–C117). American Association for Cancer Research (AACR). https://doi.org/10.1158/1538-7755.disp25-c117

George, Daniel J., Lauren E. Howard, Susan Halabi, Terry Hyslop, Bonnie LaCroix, Julia Hurrelbrink, Julie Kephart, et al. “Abstract C117: Serum dehydroepiandrosterone sulfate (DHEAS) and race associated with longer survival in patients (pts) treated with apalutamide (Apa) and abiraterone acetate (AA) plus prednisone (P) in the PANTHER study.” In Cancer Epidemiology, Biomarkers & Prevention, 34:C117–C117. American Association for Cancer Research (AACR), 2025. https://doi.org/10.1158/1538-7755.disp25-c117.

George DJ, Howard LE, Halabi S, Hyslop T, LaCroix B, Hurrelbrink J, et al. Abstract C117: Serum dehydroepiandrosterone sulfate (DHEAS) and race associated with longer survival in patients (pts) treated with apalutamide (Apa) and abiraterone acetate (AA) plus prednisone (P) in the PANTHER study. In: Cancer Epidemiology, Biomarkers & Prevention. American Association for Cancer Research (AACR); 2025. p. C117–C117.

George, Daniel J., et al. “Abstract C117: Serum dehydroepiandrosterone sulfate (DHEAS) and race associated with longer survival in patients (pts) treated with apalutamide (Apa) and abiraterone acetate (AA) plus prednisone (P) in the PANTHER study.” Cancer Epidemiology, Biomarkers & Prevention, vol. 34, no. 9_Supplement, American Association for Cancer Research (AACR), 2025, pp. C117–C117. Crossref, doi:10.1158/1538-7755.disp25-c117.

George DJ, Howard LE, Halabi S, Hyslop T, LaCroix B, Hurrelbrink J, Kephart J, Rasmussen J, Reyes-Martinez MA, Shobe K, Gray S, Anand M, Patierno SR, Armstrong AJ, Montgomery RB, Mostaghel EA, Freedman JA. Abstract C117: Serum dehydroepiandrosterone sulfate (DHEAS) and race associated with longer survival in patients (pts) treated with apalutamide (Apa) and abiraterone acetate (AA) plus prednisone (P) in the PANTHER study. Cancer Epidemiology, Biomarkers & Prevention. American Association for Cancer Research (AACR); 2025. p. C117–C117.